Cargando…
MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency
Premature ovarian insufficiency (POI) is a typical disorder of amenorrhea that lasts for a minimum of four months in women < 40 years old and is typically characterized by reduced estrogen levels and elevated serum concentrations of follicle-stimulating hormone. We collected urine samples from tw...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497098/ https://www.ncbi.nlm.nih.gov/pubmed/36139370 http://dx.doi.org/10.3390/cells11182797 |
_version_ | 1784794430123802624 |
---|---|
author | Umair, Zobia Baek, Mi-Ock Song, Jisue An, Seona Chon, Seung Joo Yoon, Mee-Sup |
author_facet | Umair, Zobia Baek, Mi-Ock Song, Jisue An, Seona Chon, Seung Joo Yoon, Mee-Sup |
author_sort | Umair, Zobia |
collection | PubMed |
description | Premature ovarian insufficiency (POI) is a typical disorder of amenorrhea that lasts for a minimum of four months in women < 40 years old and is typically characterized by reduced estrogen levels and elevated serum concentrations of follicle-stimulating hormone. We collected urine samples from two participant cohorts from Gil Hospital of Gachon University (Incheon, Korea): a sequencing cohort of 19 participants (seven patients with POI (POI patients without Turner syndrome), seven patients with Turner syndrome (POI patients with Turner syndrome), and five control individuals (age-matched controls with confirmed ovarian sufficiency)) and a validation cohort of 46 participants (15 patients with POI, 11 patients with Turner syndrome, and 20 control individuals). Among differentially expressed miRNAs, hsa-miR-4516 was significantly upregulated in patients with POI in both cohorts, independent of the presence of Turner syndrome. Moreover, the upregulation of miR-4516 was confirmed in the ovary—but not in the uterus—of a cyclophosphamide and busulfan-induced POI mouse model. This was accompanied by a decrease in STAT3 protein level, a predicted target of miR-4516, via miRTarBase2020. Our study provides compelling evidence that miR-4516 is highly expressed in patients with POI and POI mouse models, suggesting that miR-4516 is a diagnostic marker of POI. |
format | Online Article Text |
id | pubmed-9497098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94970982022-09-23 MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency Umair, Zobia Baek, Mi-Ock Song, Jisue An, Seona Chon, Seung Joo Yoon, Mee-Sup Cells Article Premature ovarian insufficiency (POI) is a typical disorder of amenorrhea that lasts for a minimum of four months in women < 40 years old and is typically characterized by reduced estrogen levels and elevated serum concentrations of follicle-stimulating hormone. We collected urine samples from two participant cohorts from Gil Hospital of Gachon University (Incheon, Korea): a sequencing cohort of 19 participants (seven patients with POI (POI patients without Turner syndrome), seven patients with Turner syndrome (POI patients with Turner syndrome), and five control individuals (age-matched controls with confirmed ovarian sufficiency)) and a validation cohort of 46 participants (15 patients with POI, 11 patients with Turner syndrome, and 20 control individuals). Among differentially expressed miRNAs, hsa-miR-4516 was significantly upregulated in patients with POI in both cohorts, independent of the presence of Turner syndrome. Moreover, the upregulation of miR-4516 was confirmed in the ovary—but not in the uterus—of a cyclophosphamide and busulfan-induced POI mouse model. This was accompanied by a decrease in STAT3 protein level, a predicted target of miR-4516, via miRTarBase2020. Our study provides compelling evidence that miR-4516 is highly expressed in patients with POI and POI mouse models, suggesting that miR-4516 is a diagnostic marker of POI. MDPI 2022-09-07 /pmc/articles/PMC9497098/ /pubmed/36139370 http://dx.doi.org/10.3390/cells11182797 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Umair, Zobia Baek, Mi-Ock Song, Jisue An, Seona Chon, Seung Joo Yoon, Mee-Sup MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency |
title | MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency |
title_full | MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency |
title_fullStr | MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency |
title_full_unstemmed | MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency |
title_short | MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency |
title_sort | microrna-4516 in urinary exosomes as a biomarker of premature ovarian insufficiency |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497098/ https://www.ncbi.nlm.nih.gov/pubmed/36139370 http://dx.doi.org/10.3390/cells11182797 |
work_keys_str_mv | AT umairzobia microrna4516inurinaryexosomesasabiomarkerofprematureovarianinsufficiency AT baekmiock microrna4516inurinaryexosomesasabiomarkerofprematureovarianinsufficiency AT songjisue microrna4516inurinaryexosomesasabiomarkerofprematureovarianinsufficiency AT anseona microrna4516inurinaryexosomesasabiomarkerofprematureovarianinsufficiency AT chonseungjoo microrna4516inurinaryexosomesasabiomarkerofprematureovarianinsufficiency AT yoonmeesup microrna4516inurinaryexosomesasabiomarkerofprematureovarianinsufficiency |